This article has been updated to reflect further commentary made by the company.

NEW YORK (GenomeWeb) – Last month, iCareDx announced that it was rebranding itself as Acuamark Diagnostics as it works to raise funds for its first round of clinical testing.

"It is a more precise reflection of what we are doing," Acuamark President and CEO Bernard Peperstraete told GenomeWeb. "Acua is also a play on accurate and liquid, and Acuamark — or watermark — reflects that each cancer leaves a barely visible imprint, and needs to be looked at in a different light."

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

A trial upgrade to 360Dx Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try 360Dx Premium now.

Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.